Veralto director granted stock units and options

Wallis-Lage Cindy L. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Wallis-Lage Cindy L. reported acquisition or exercise transactions in this Form 4 filing.

Veralto Corp director Cindy L. Wallis-Lage received equity awards. She was granted 1,009 restricted stock units that vest on the earlier of the first anniversary of the grant or the next annual shareholders meeting, with shares issued only after board retirement or death. She also received 3,553 fully vested director stock options to buy common shares at $91.00 per share, expiring in 2036, bringing her holdings to 3,380 common shares and 9,413 options held directly.

Insider Trade Summary

Grant/Award: 4,562 shares

Grant/Award 2 txns

Insider Wallis-Lage Cindy L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Stock Option (Right to Buy) F2	3,553	$0.00	$0.00
Grant/Award	Common Stock F1	1,009	$0.00	$0.00

Holdings After Transaction: Director Stock Option (Right to Buy) — 9,413 contracts (Direct); Common Stock — 3,380 shares (Direct)

Footnotes (2)

1. F1. Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
2. F2. The options granted to our non-employee directors will be fully vested as of the grant date.

Key Figures

Restricted stock units granted: 1,009 units Director stock options granted: 3,553 options Option exercise price: $91.00 per share +3 more

6 metrics

Restricted stock units granted 1,009 units RSU grant to Cindy L. Wallis-Lage on 2026-07-15

Director stock options granted 3,553 options Director stock option grant on 2026-07-15

Option exercise price $91.00 per share Exercise price for 3,553 director stock options

Common shares held after grants 3,380 shares Direct Veralto common stock holdings following RSU grant

Options held after grants 9,413 options Total director stock options held directly after new grant

Option expiration date 2036-07-15 Expiry of director stock options granted on 2026-07-15

Key Terms

restricted stock units, Director Stock Option (Right to Buy), non-employee directors, exercise price, +1 more

5 terms

restricted stock units financial

"Reflects a grant of restricted stock units that vest on the earlier of"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Director Stock Option (Right to Buy) financial

"security_title: Director Stock Option (Right to Buy)"

non-employee directors financial

"The options granted to our non-employee directors will be fully vested"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

exercise price financial

"conversion_or_exercise_price: "91.0000" for the director stock options"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

annual meeting of Veralto's shareholders financial

"vest on the earlier of the first anniversary or the date of the next annual meeting of Veralto's shareholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Veralto (VLTO) report for director Cindy L. Wallis-Lage?

Veralto reported that director Cindy L. Wallis-Lage received equity awards, not open-market trades. She was granted 1,009 restricted stock units and 3,553 director stock options as part of non-employee director compensation on July 15, 2026.

How many restricted stock units did Cindy L. Wallis-Lage receive at Veralto (VLTO)?

Cindy L. Wallis-Lage received a grant of 1,009 restricted stock units. These RSUs vest on the earlier of the first anniversary of the grant or the next annual shareholders meeting, with underlying shares issued only after retirement from the board or death.

What are the terms of the stock options granted to the Veralto (VLTO) director?

She received 3,553 director stock options with an exercise price of $91.00 per share. The options were fully vested as of the grant date and are exercisable for Veralto common stock until their expiration on July 15, 2036.

When do Cindy L. Wallis-Lage’s Veralto (VLTO) restricted stock units vest and settle?

The RSUs vest on the earlier of the first anniversary of the grant date or the next annual shareholders meeting. However, the underlying shares are issued only at the earlier of her death or the first date of the seventh month after retiring from Veralto’s board.

What are Cindy L. Wallis-Lage’s Veralto (VLTO) holdings after these grants?

After these equity awards, Cindy L. Wallis-Lage directly holds 3,380 shares of Veralto common stock and 9,413 director stock options. These positions reflect her ownership immediately following the July 15, 2026 grants reported in the insider filing.

Were Cindy L. Wallis-Lage’s Veralto (VLTO) transactions under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and the transactions are coded as grant or award acquisitions for director compensation, not pre-arranged trading plan purchases or sales in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/17/2026 - 05:44 PM Accepted by SEC EDGAR 07/17/2026 - 05:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wallis-Lage Cindy L.

(Last) (First) (Middle)

C/O VERALTO CORPORATION

225 WYMAN STREET, SUITE 250

(Street)

WALTHAM MASSACHUSETTS 02451

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Veralto Corp [ VLTO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2026		A		1,009(1)	A	$0	3,380	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (Right to Buy)	$91	07/15/2026		A		3,553(2)		07/15/2026	07/15/2036	Common Stock	3,553	$0	9,413	D

Explanation of Responses:

1. Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.

2. The options granted to our non-employee directors will be fully vested as of the grant date.

Remarks:

	/s/ James Tanaka, as attorney-in-fact	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)